নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm as - doksepinhydroklorid - kapsel, hard - 25 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm as - nystatin - mikstur, suspensjon - 100000 ie/ ml

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

2care4 - nystatin - mikstur, suspensjon - 100000 ie/ ml

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

orifarm as - nystatin - mikstur, suspensjon - 100000 ie/ ml

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

intervet international b.v. - fenbendazol - tablett - 500 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

intervet international b.v. - fenbendazol - tablett - 250 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

baxter medical ab - retinylpalmitat / kolekalsiferol / tokoferol alfa / askorbinsyre / tiamin / riboflavinnatriumfosfathydrat / pyridoksinhydroklorid / cyanokobalamin / folsyre / pantotensyre / biotin / nikotinamid - pulver til injeksjons-/infusjonsvæske, oppløsning - 3500 ie / 220 ie / 11.2 ie / 125 mg / 3.51 mg / 4.14 mg / 4.53 mg / 0.006 mg / 0.414 mg / 17.25 mg / 0.069 mg / 46 mg

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

b. braun melsungen ag - tokoferol, helracemisk, a- / askorbinsyre / biotin / kolekalsiferol / cyanokobalamin / dekspantenol / folsyre / nikotinamid / fytomenadion / pyridoksinhydroklorid / retinylpalmitat / riboflavinnatriumfosfathydrat / tiaminhydroklorid - pulver til infusjonsvæske, oppløsning

ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

menarini international operations luxembourg s.a. - oritavancin (diphosphate) - soft tissue infections; skin diseases, bacterial - antibakterielle midler for systemisk bruk, - tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and paediatric patients aged 3 months and older (see sections 4. 2, 4. 4 og 5. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

aspen pharma trading limited - Østriol - tablett - 1 mg